Systems pharmacology uncover the mechanism of anti-non-small cell lung cancer for Hedyotis diffusa Willd - 09/12/18
pages | 16 |
Iconographies | 9 |
Vidéos | 0 |
Autres | 0 |
Graphical abstract |
Highlights |
• | Hedyotis diffusa Willd is an important traditional Chinese medicine (TCM) that is used in clinical treatment of cancers, in vivo studies clearly showed that Hedyotis diffusa Willd has anti- tumor activity and extended its life cycle. |
• | Absorption, distribution, metabolism and excretion (ADME) evaluation, systematic drug targeting tool and weighted ensemble similarity algorithm are employed to predict potential drug target and analysis. |
• | The multiple pathways mainly target by regulation of MAP kinase activity signaling pathway, regulation of angiogenesis pathway, and proliferation and apoptosis pathway. |
• | The selected active compound kaempferol inhibits proliferation, inflammation and angiogenesis by reducing the expression of protein levels of CDK2, COX-2, iNOS, p38 and eNOS. |
Abstract |
Non-small cell lung cancer (NSCLC) has become one of the most general malignancies in the world and has been shown to be the leading cause of cancer-related deaths. Traditional Chinese medicine (TCM) is considered to be a useful medicine for survival, and has been used in Asia for thousands of years. Hedyotis diffusa Willd (HDW) is an important folk herb that is used in clinical treatment of various cancers in various Chinese medicine prescriptions. However, its underlying mechanism of action remains unclear. Presently, we used an innovative system-pharmacology platform to systematically uncover the pharmacological mechanisms of HDW in the treatment of NSCLC from molecules, targets, and pathway levels. The results show that HDW treatment of NSCLC may activate immunity, achieve anti-inflammatory, anti-proliferative and anti-migration therapeutic effects by regulating multiple pathways. This research provides a new idea for understanding the mechanism of TCM and promotes to develop potential drugs from HDW in modern medicine.
Le texte complet de cet article est disponible en PDF.Keywords : Hedyotis diffusa Willd, Antitumor, Systems pharmacology, Non-small cell lung cancer, Traditional Chinese medicine
Plan
Vol 109
P. 969-984 - janvier 2019 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?